Number of tablets - Retention at two different CROs [Regulatives / Guidelines]

posted by scorp2011 – India, 2014-03-18 08:35 (4483 d 21:19 ago) – Posting: # 12644
Views: 3,529

Dear Team,
Please guide me:

Study 1 of XYZ product conducted at CRO 1. Now we are planning to conduct Study 2 of same XYZ product at a different CRO 2. Please suggest the requirement for retention of investigational products to be retained. Do we need to retain samples required for 5-times release test at each CRO (say for example 300 samples at CRO 1 and 300 samples at CRO 2) or else will a total of 300 samples combined at both the CRO's will suffice (say for example 200 at CRO 1 and 100 at CRO 2).

Regards
Sonu

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
264 visitors (0 registered, 264 guests [including 23 identified bots]).
Forum time: 06:54 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5